NCT07651215

Brief Summary

Reverse total shoulder arthroplasty (RTSA) has become increasingly common in recent years due to expanding indications and improved surgical techniques. Short-stem humeral implants have gained attention because they preserve bone stock, allow metaphyseal fixation, and facilitate potential revision procedures. The aim of this study is to evaluate radiographic and clinical outcomes following reverse shoulder arthroplasty with a short humeral stem after a minimum follow-up of two years. Patients who underwent RTSA at the Department of Orthopedics at Ordensklinikum Linz will be invited for clinical and radiographic follow-up. Clinical outcomes will be assessed using established shoulder scores including the Constant Score, the American Shoulder and Elbow Surgeons (ASES) score, and the Simple Shoulder Test (SST). Radiographic evaluation will focus on humeral-sided changes such as stress shielding, radiolucent lines, osteolysis, and fractures. Patient satisfaction will additionally be assessed using visual analogue scales and patient-reported outcome measures. Demographic variables, comorbidities, and implant-related characteristics will be collected to allow descriptive evaluation of factors potentially associated with clinical and radiographic outcomes.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
5mo left

Started Feb 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Feb 2026Dec 2026

Study Start

First participant enrolled

February 1, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 1, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 16, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

June 16, 2026

Status Verified

June 1, 2026

Enrollment Period

11 months

First QC Date

June 1, 2026

Last Update Submit

June 10, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Radiographic Changes of the Humeral Component

    Assessment of humeral-sided radiographic changes including: Stress shielding Radiolucent lines Osteolysis Periprosthetic fractures Measured using standardized radiographs at follow-up.

    ≥2 years postoperatively

Secondary Outcomes (4)

  • Constant-Murley Score (Constant Score)

    up to 3 years postoperatively

  • American Shoulder and Elbow Surgeons Score (ASES)

    up to 3 years postoperatively

  • Simple Shoulder Test Score (SST)

    up to 3 Years Postoperatively

  • Return to Sport Rate (RTS)

    up to 3 years postoperatively

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adult patients who underwent reverse total shoulder arthroplasty with a short humeral stem at the Department of Orthopedics, Ordensklinikum Linz, Austria. All eligible patients who received this procedure at least two years prior to enrollment will be invited for a clinical and radiographic follow-up examination. Participants are identified through institutional medical records and include both male and female patients. Only patients who provide written informed consent will be included in the study.

You may qualify if:

  • Reverse shoulder arthroplasty with short humeral stem
  • Surgery performed at Ordensklinikum Linz
  • Minimum postoperative follow-up of 2 years
  • Written informed consent

You may not qualify if:

  • Perioperative complications not related to the surgical procedure
  • Lack of consent for study participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ordensklinikum Linz - Barmherzige Schwester

Linz, 3340, Austria

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 1, 2026

First Posted

June 16, 2026

Study Start

February 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

June 16, 2026

Record last verified: 2026-06

Locations